These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27913896)

  • 1. Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction.
    Chen L; Zhang Y; Tao L; Yang Z; Wang L
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):9-18. PubMed ID: 27913896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of mesenchymal stem cells overexpressing IL10 attenuates cardiac impairments in rats with myocardial infarction.
    Meng X; Li J; Yu M; Yang J; Zheng M; Zhang J; Sun C; Liang H; Liu L
    J Cell Physiol; 2018 Jan; 233(1):587-595. PubMed ID: 28322445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minicircle DNA-mediated endothelial nitric oxide synthase gene transfer enhances angiogenic responses of bone marrow-derived mesenchymal stem cells.
    Bandara N; Gurusinghe S; Chen H; Chen S; Wang LX; Lim SY; Strappe P
    Stem Cell Res Ther; 2016 Apr; 7():48. PubMed ID: 27036881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
    Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
    Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
    Kanki-Horimoto S; Horimoto H; Mieno S; Kishida K; Watanabe F; Furuya E; Katsumata T
    Circulation; 2006 Jul; 114(1 Suppl):I181-5. PubMed ID: 16820570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic vascular prosthesis impregnated with mesenchymal stem cells overexpressing endothelial nitric oxide synthase.
    Kanki-Horimoto S; Horimoto H; Mieno S; Kishida K; Watanabe F; Furuya E; Katsumata T
    Circulation; 2006 Jul; 114(1 Suppl):I327-30. PubMed ID: 16820594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance.
    Zeng B; Chen H; Zhu C; Ren X; Lin G; Cao F
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):850-6. PubMed ID: 18640847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deterioration of cardiac function after acute myocardial infarction is prevented by transplantation of modified endothelial progenitor cells overexpressing endothelial NO synthases.
    Chen X; Gu M; Zhao X; Zheng X; Qin Y; You X
    Cell Physiol Biochem; 2013; 31(2-3):355-65. PubMed ID: 23485722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
    Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction.
    Chen Q; Varga M; Wang X; Haddad DJ; An S; Medzikovic L; Derakhshandeh R; Kostyushev DS; Zhang Y; Clifford BT; Luu E; Danforth OM; Rafikov R; Gong W; Black SM; Suchkov SV; Fineman JR; Heiss C; Aschbacher K; Yeghiazarians Y; Springer ML
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase.
    Song L; Yang YJ; Dong QT; Qian HY; Gao RL; Qiao SB; Shen R; He ZX; Lu MJ; Zhao SH; Geng YJ; Gersh BJ
    PLoS One; 2013; 8(5):e65702. PubMed ID: 23741509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
    Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
    Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase promotes bone marrow stromal cell migration to the ischemic myocardium via upregulation of stromal cell-derived factor-1alpha.
    Li N; Lu X; Zhao X; Xiang FL; Xenocostas A; Karmazyn M; Feng Q
    Stem Cells; 2009 Apr; 27(4):961-70. PubMed ID: 19353524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats.
    Gao F; He T; Wang H; Yu S; Yi D; Liu W; Cai Z
    Can J Cardiol; 2007 Sep; 23(11):891-8. PubMed ID: 17876381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.